| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 421-428 |
| Journal | Seminars in Arthritis and Rheumatism |
| Volume | 43 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2014 |
Cite this
Roman-Blas, J. A., Castaneda, S., Largo, R., Lems, W. F., & Herrero-Beaumont, G. (2014). An OA phenotype may obtain major benefit from bone-acting agents. Seminars in Arthritis and Rheumatism, 43(4), 421-428. https://doi.org/10.1016/j.semarthrit.2013.07.012
@article{1ce34c57cf844eaa8383392cd82cbbb6,
title = "An OA phenotype may obtain major benefit from bone-acting agents",
author = "J.A. Roman-Blas and S. Castaneda and R. Largo and W.F. Lems and G. Herrero-Beaumont",
year = "2014",
doi = "10.1016/j.semarthrit.2013.07.012",
language = "Undefined/Unknown",
volume = "43",
pages = "421--428",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "4",
}
Roman-Blas, JA, Castaneda, S, Largo, R, Lems, WF & Herrero-Beaumont, G 2014, 'An OA phenotype may obtain major benefit from bone-acting agents' Seminars in Arthritis and Rheumatism, vol. 43, no. 4, pp. 421-428. https://doi.org/10.1016/j.semarthrit.2013.07.012
An OA phenotype may obtain major benefit from bone-acting agents. / Roman-Blas, J.A.; Castaneda, S.; Largo, R.; Lems, W.F.; Herrero-Beaumont, G.
In: Seminars in Arthritis and Rheumatism, Vol. 43, No. 4, 2014, p. 421-428.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - An OA phenotype may obtain major benefit from bone-acting agents
AU - Roman-Blas, J.A.
AU - Castaneda, S.
AU - Largo, R.
AU - Lems, W.F.
AU - Herrero-Beaumont, G.
PY - 2014
Y1 - 2014
U2 - 10.1016/j.semarthrit.2013.07.012
DO - 10.1016/j.semarthrit.2013.07.012
M3 - Article
VL - 43
SP - 421
EP - 428
JO - Seminars in Arthritis and Rheumatism
JF - Seminars in Arthritis and Rheumatism
SN - 0049-0172
IS - 4
ER -
Roman-Blas JA, Castaneda S, Largo R, Lems WF, Herrero-Beaumont G. An OA phenotype may obtain major benefit from bone-acting agents. Seminars in Arthritis and Rheumatism. 2014;43(4):421-428. https://doi.org/10.1016/j.semarthrit.2013.07.012